MEDLAB CLINICAL LIMITED

0.00%

$6.60

Currently unlisted.

Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals with the objective of empowering patients with chronic diseases and mental health conditions and enhancing their lives. Its drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress. It also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. It is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Latest Threads

Tag

Subject

MDC

Ann: Removal from Official List

28/02/25

845

28/02/25

Last post

ASX News

845

MDC

Ann: Results of Meeting 2024

14/02/25

448

14/02/25

Last post

ASX News

448

MDC

Ann: Results of Meeting 2023

14/02/25

348

14/02/25

Last post

ASX News

348

MDC

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

11/02/25

2.2K

11/02/25

Last post Traze

2.2K

MDC

Ann: Notice of Annual General Meeting/Proxy Form

29/01/25

2.3K

29/01/25

Last post Traze

2.3K

MDC

Ann: Long Term Suspended Entities

22/01/25

409

22/01/25

Last post

ASX News

409

MDC

Ann: Notice of General Meeting/Proxy Form

10/01/25

330

10/01/25

Last post

ASX News

330

MDC

Ann: MDC Board Composition Changes

15/12/24

2.2K

15/12/24

Last post jcurve

2.2K

See All Discussions

Timeline

Removal from Official List
28 Feb 09:20	Share

Results of Meeting 2024
14 Feb 09:16	Share

Results of Meeting 2023
14 Feb 09:15	Share

Quarterly Activities/Appendix 4C Cash Flow Report
03 Feb 14:08	Share

Long Term Suspended Entities
22 Jan 16:20	Share

Notice of Annual General Meeting/Proxy Form
10 Jan 16:08	Share

Notice of General Meeting/Proxy Form
10 Jan 16:08	Share

Response to Appendices 3X and 3Z Query
13 Dec 09:54	Share

Final Director's Interest Notice
04 Dec 14:59	Share

Initial Director's Interest Notice
04 Dec 14:58	Share

MDC Board Composition Changes
04 Dec 14:56	Share

Annual Report to shareholders
04 Nov 11:40	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 13:41	Share

Long Term Suspended Entities
18 Oct 16:15	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 13:39	Share

Long Term Suspended Entities
10 Jul 16:15	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

MEDLAB CLINICAL LIMITED

Latest Threads

Hear From ASX Company Leaders – Watch Exclusive Interviews here!

Timeline

Featured News

Latest Articles

Medlab Clinical (ASX:MDC) gets green light to bring NanaBis into UK

Medlab Clinical (ASX:MDC) has received certification to import its NanaBis drug into the United Kingdom, helping pave the way to receiving market authority in the country.

Top Stories

Featured News